These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 39034725)

  • 1. Shape Dependent Therapeutic Potential of Nanoparticulate System: Advance Approach for Drug Delivery.
    Verma S; Malviya R; Srivastava S; Ahmad I; Singh B; Almontasheri R; Uniyal P
    Curr Pharm Des; 2024; 30(33):2606-2618. PubMed ID: 39034725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmaceutical development and regulatory considerations for nanoparticles and nanoparticulate drug delivery systems.
    Narang AS; Chang RK; Hussain MA
    J Pharm Sci; 2013 Nov; 102(11):3867-82. PubMed ID: 24037829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strategies in the design of nanoparticles for therapeutic applications.
    Petros RA; DeSimone JM
    Nat Rev Drug Discov; 2010 Aug; 9(8):615-27. PubMed ID: 20616808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanostructured materials for applications in drug delivery and tissue engineering.
    Goldberg M; Langer R; Jia X
    J Biomater Sci Polym Ed; 2007; 18(3):241-68. PubMed ID: 17471764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physical and chemical strategies for therapeutic delivery by using polymeric nanoparticles.
    Morachis JM; Mahmoud EA; Almutairi A
    Pharmacol Rev; 2012 Jul; 64(3):505-19. PubMed ID: 22544864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Applications of mesoporous materials as excipients for innovative drug delivery and formulation.
    Shen SC; Ng WK; Chia LS; Dong YC; Tan RB
    Curr Pharm Des; 2013; 19(35):6270-89. PubMed ID: 23470004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent update of toxicity aspects of nanoparticulate systems for drug delivery.
    Patnaik S; Gorain B; Padhi S; Choudhury H; Gabr GA; Md S; Kumar Mishra D; Kesharwani P
    Eur J Pharm Biopharm; 2021 Apr; 161():100-119. PubMed ID: 33639254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanosize drug delivery system.
    Mukherjee B
    Curr Pharm Biotechnol; 2013; 14(15):1221. PubMed ID: 25106648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nano-formulations of drugs: Recent developments, impact and challenges.
    Jeevanandam J; Chan YS; Danquah MK
    Biochimie; 2016; 128-129():99-112. PubMed ID: 27436182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Engineered Hybrid Nanoparticles for On-Demand Diagnostics and Therapeutics.
    Nguyen KT; Zhao Y
    Acc Chem Res; 2015 Dec; 48(12):3016-25. PubMed ID: 26605438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Has nanotechnology led to improved therapeutic outcomes?
    Bosselmann S; Williams RO
    Drug Dev Ind Pharm; 2012 Feb; 38(2):158-70. PubMed ID: 22191583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mesoporous Silica Platforms with Potential Applications in Release and Adsorption of Active Agents.
    Chircov C; Spoială A; Păun C; Crăciun L; Ficai D; Ficai A; Andronescu E; Turculeƫ ȘC
    Molecules; 2020 Aug; 25(17):. PubMed ID: 32825791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rod-shaped mesoporous silica nanoparticles for nanomedicine: recent progress and perspectives.
    Cong VT; Gaus K; Tilley RD; Gooding JJ
    Expert Opin Drug Deliv; 2018 Sep; 15(9):881-892. PubMed ID: 30173560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disposition of nanoparticle-based delivery system via inner ear administration.
    Chen G; Zhang X; Yang F; Mu L
    Curr Drug Metab; 2010 Dec; 11(10):886-97. PubMed ID: 21208174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unique benefits of nanotechnology to drug delivery and diagnostics.
    McNeil SE
    Methods Mol Biol; 2011; 697():3-8. PubMed ID: 21116949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safe Nanoparticles: Are We There Yet?
    Najahi-Missaoui W; Arnold RD; Cummings BS
    Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33396561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of Polydopamine-Coated Mesoporous Silica Nanorods and Spheres for the Delivery of Hydrophilic and Hydrophobic Anticancer Drugs.
    Pada AK; Desai D; Sun K; Prakirth Govardhanam N; Törnquist K; Zhang J; Rosenholm JM
    Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31336697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advances in the synthesis and application of nanoparticles for drug delivery.
    Park W; Na K
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2015; 7(4):494-508. PubMed ID: 25583540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted Drug Delivery Based on Gold Nanoparticle Derivatives.
    Gholipourmalekabadi M; Mobaraki M; Ghaffari M; Zarebkohan A; Omrani VF; Urbanska AM; Seifalian A
    Curr Pharm Des; 2017; 23(20):2918-2929. PubMed ID: 28425863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanoparticles for cellular drug delivery: mechanisms and factors influencing delivery.
    Chavanpatil MD; Khdair A; Panyam J
    J Nanosci Nanotechnol; 2006; 6(9-10):2651-63. PubMed ID: 17048473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.